Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
The number of patients diagnosed with endometrial cancer in Kaiser Permanente Northern California during the first 12 weeks of the COVID-19 pandemic was more than one-third lower than what would be expected, a new Kaiser Permanente study found.
Young people with autism use more health care services and need assistance transitioning from pediatric to adult medical care, according to 2 new studies by researchers with the Kaiser Permanente Division of Research.
Kaiser Permanente’s rich history of research and care delivery innovation around HIV and AIDS will be highlighted at the global International AIDS Conference, being held online July 6-10.
Patients reported positive outcomes with use of an HIV prevention medication dosed only as needed, instead of the more common daily dosing, Kaiser Permanente researchers reported.
A Kaiser Permanente randomized controlled trial comparing an in-person diabetes prevention program with an online version found both helped San Francisco City and County employees at risk for developing diabetes to lose weight.
New findings from Kaiser Permanente Division of Research SWIFT Study in PLOS Medicine advance a potential blood test to predict which women with gestational diabetes will go on to develop type 2 diabetes.
New research by Kaiser Permanente shows the weekly number of patients admitted to Kaiser Permanente Northern California hospitals with acute myocardial infarction (heart attacks) fell to nearly half of what would be expected after the onset of the COVID-19 pandemic.
An analysis of 2.7 million Kaiser Permanente patients finds a higher risk of unhealthful drinking among people who drink and have chronic obstructive pulmonary disease (COPD), chronic liver disease, diabetes, and hypertension.
A new Kaiser Permanente research paper explains how Kaiser Permanente Northern California quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic.
A JAMA study, using data on patients hospitalized in March from all 21 Kaiser Permanente Northern California hospitals, is one of the first U.S. studies to look at overall hospitalization admissions of COVID-19 patients.
